cerebral folate deficiency

Maxwell Hamilton / Wikimedia (CC BY-SA 3.0)

FDA Withdraws Approval for GSK's Leucovorin in Treating Cerebral Folate Deficiency

The U.S. Food and Drug Administration is withdrawing approval for GlaxoSmithKline's leucovorin as a treatment for cerebral folate deficiency, a rare brain disorder. GSK stated that the withdrawal was anticipated as part of the original approval plan. The disorder involves symptom…